TrialBMC medicine2022

Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a phase II, single-arm study.

Lugui Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.